Paratek Pharmaceuticals Garners $18,000,000 New Financing

  • Feed Type
  • Date
    4/16/2008
  • Company Name
    Paratek Pharmaceuticals
  • Mailing Address
    75 Kneeland Street Boston, MA 02111
  • Company Description
    Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases.
  • Website
    http://www.paratekpharm.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. This is part of a $40 million funding.
  • M&A Terms
  • Venture Investor
    Aisling Capital
  • Venture Investor
    D. E. Shaw Group
  • Venture Investor
    Nomura Phase4 Ventures
  • Venture Investor
    Novartis BioVenture Fund
  • Venture Investor
    HBM Bioventures
  • Venture Investor
    Hercules Technology Growth Capital

By posting a comment, you agree to our terms and conditions.